Stranica 1 iz 24 rezultatima
The invention relates to the use of pyridyl aklane, pyridyl alkene and/or pyridyl alkine acid amides, especially in the treatment of tumor conditions and/or as cytostatic agents or as immunosuppressive agents as well as medicaments with an amount of these compounds in combination with other
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to methods of detecting and diagnosing lung cancers in mammals.
2. Brief Description of Related Art
Primary carcinoma of the lung is the leading cause of cancer death in the United States. Every year, more than 100,000 males
FIELD OF THE INVENTION
The present invention relates to a method for detecting cancer, and more particularly to a method for detecting cancer based on physisorption kinetics of reagent.
DESCRIPTION OF THE PRIOR ART
At an early phase of cancer, it is difficult to diagnose cancer in a clinic as it is
The invention relates to new pyridine compounds, methods for their production, medicaments containing these compounds as well as their use, especially in the treatment of tumor conditions and/or as cytostatic agents or as immunosuppressive agents.
A strong need exists for the enrichment of
The invention relates to new pyridine compounds, methods for their production, medicaments containing these compounds as well as their use, especially in the treatment of tumor conditions and/or as cytostatic agents or as immunosuppressive agents.
A strong need exists for the enrichment of
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
None
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention refers to production of a synthetic compound termed 4,4'-(4'-Carboxy)-4-nonyloxy-[1,1'-biphenyl]-3,5-diyl)dibutanoic acid (hereinafter referred to as "CNBDA"),
This application is the US national phase of international application PCT/GB02/04933 filed in English on 31 Oct. 2002, which designated the US. PCT/GB02/04933 claims priority to GB Application No. 0126157.7 filed 31 Oct. 2001. The entire contents of these applications are incorporated herein by
FIELD OF THE INVENTION
The present invention relates to aza spiro alkane compounds which are useful in treating diseases, pathologic conditions and disorders associated with metalloprotease activity, including activity of sheddases and adamalysins (ADAMs).
BACKGROUND OF THE INVENTION
Most tissues
FIELD OF THE INVENTION
The present invention relates to aza spiro alkane compounds which are useful in treating diseases, pathologic conditions and disorders associated with metalloprotease activity, including activity of sheddases and adamalysins (ADAMs).
BACKGROUND OF THE INVENTION
Most tissues
FIELD OF THE INVENTION
The present invention relates to aza spiro alkane compounds which are useful in treating diseases, pathologic conditions and disorders associated with metalloprotease activity, including activity of sheddases and adamalysins (ADAMs).
BACKGROUND OF THE INVENTION
Most tissues
FIELD OF THE INVENTION
The present invention relates to aza spiro alkane compounds which are useful in treating diseases, pathologic conditions and disorders associated with metalloprotease activity, including activity of sheddases and adamalysins (ADAMs).
BACKGROUND OF THE INVENTION
Most tissues
FIELD OF THE INVENTION
The present invention relates to aza spiro alkane compounds which are useful in treating diseases, pathologic conditions and disorders associated with metalloprotease activity, including activity of sheddases and adamalysins (ADAMs).
BACKGROUND OF THE INVENTION
Most tissues
FIELD OF THE INVENTION
The present invention relates to aza spiro alkane compounds which are useful in treating diseases, pathologic conditions and disorders associated with metalloprotease activity, including activity of sheddases and adamalysins (ADAMs).
BACKGROUND OF THE INVENTION
Most tissues
FIELD OF THE INVENTION
The present invention relates to azaspiro alkane compounds which are useful in treating diseases, pathologic conditions and disorders associated with metalloprotease activity, including activity of sheddases and adamalysins (ADAMs).
BACKGROUND OF THE INVENTION
Most tissues
FIELD OF THE INVENTION
This invention relates to compounds which are inhibitors of protein tyrosine phosphatases (PTPases), which are useful for the management, treatment, control, or adjunct treatment of diseases caused by over-activity of PTPases.
BACKGROUND OF THE INVENTION
The process of protein